VICTOR: vinflunine in advanced metastatic transitional cell carcinoma of the urothelium (TCCU): a retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through free of charge programme (FOCP) for patients in the UK and Ireland.
Authors
Hussain, SAnsari, J
Huddart, R
Power, D
Lyons, Jeanette
Wylie, James P
Vilarino-Varela, M
Elander, N
McMenemin, R
Pickering, L
Faust, G
Chauhan, S
Jakson, R
Affiliation
Molecular and Clinical Cancer Medicine, University of Liverpool-Royal Liverpool University Hospital, LiverpoolIssue Date
2016-10-01
Metadata
Show full item recordCitation
VICTOR: vinflunine in advanced metastatic transitional cell carcinoma of the urothelium (TCCU): a retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through free of charge programme (FOCP) for patients in the UK and Ireland. 2016, 27(suppl 6):800P Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdw373.28Additional Links
https://academic.oup.com/annonc/article/2799537/VICTOR:Type
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdw373.28